Physician profile

Narayan C Reddy

Pulmonary Disease · Dayton, OH

NPI 1326072687

$821.08

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$127.80

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $215.28 2021
Angiodynamics, INC. $144.15 2022
Abbott Laboratories $127.80 2024 Jeti All In One Non-Sterile Kit
Jazz Pharmaceuticals INC. $123.06 2019
Medtronic Vascular, INC. $81.54 2019
Lilly USA, LLC $74.12 2019
Cardiovascular Systems INC. $28.50 2019
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $14.65 2020
Chiesi USA, INC. $11.98 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Narayan C Reddy

$821.08

in general payments reported 2019-2025

Years
2019-2024
Top company
Shockwave Medical, INC

https://glasscript.com/doctor/429431/narayan-c-reddy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.